Essex Investment Management CO LLC Medi Wound Ltd. Transaction History

Essex Investment Management CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.35 - $2.24 $393,236 - $652,480	291,286 New	291,286 $405,000
Q2 2021 Aug 12, 2021	SELL	$3.38 - $5.71 $1.12 Million - $1.89 Million	-331,394 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$3.77 - $6.05 $249,129 - $399,796	66,082 Added 24.91%	331,394 $1.78 Million
Q4 2020 Feb 12, 2021	BUY	$3.12 - $4.08 $827,773 - $1.08 Million	265,312 New	265,312 $982,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $634M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.